Arterial Hypertension and Diabetes Mellitus as Risk Factors in the Evolution of Patients with COVID-19

Carlos Miguel Campos Sanchez; Jose Carlos Garcia Roque; Liz Greit Garcia Rodriguez; Laura Adalys Guillen Leon; Juan Miguel Garcia Velazquez; Isbety Acosta Escanaverino; Daniel Rodriguez Hurtado

doi:doi:10.11648/j.ajlm.20210602.12

Arterial Hypertension and Diabetes Mellitus as Risk Factors in the Evolution of Patients with COVID-19

Carlos Miguel Campos Sanchez, Jose Carlos Garcia Roque, Liz Greit Garcia Rodriguez, Laura Adalys Guillen Leon, Juan Miguel Garcia Velazquez, Isbety Acosta Escanaverino, Daniel Rodriguez Hurtado

Published in American Journal of Laboratory Medicine (Volume 6, Issue 2)

Received: 13 March 2021 Accepted: 6 April 2021 Published: 16 April 2021

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

COVID-19 is one of the most relevant pathologies in recent months, becoming one of the most deadly pandemics that the world has faced; Since the detection of the first cases in Wuhan (China) until today, the evolution of those infected has been a bit unpredictable, although without a doubt comorbidities such as Diabetes Mellitus (DM) and Arterial Hypertension (HTN) have been an essential link in fatality of clinical evolutions and the main cause of transfer to intensive care units. A bibliographic analysis was carried out, using the Scielo, Scopus, EBSCO and Google Academic databases, where information was obtained from twenty-two bibliographic references in order to determine the influence of arterial hypertension and diabetes as risk factors in the evolution of patients with covid 19. Patients diagnosed with COVID-19 who have hypertension and diabetes as a personal medical history are more likely to develop complications during the course of the disease and even die. The control and isolation of these patients is of special importance, taking into account the risk posed by presenting these pathologies. The research work carried out in Cuba maintains the control and knowledge of the health personnel of the state of vulnerable patients.

Published in	American Journal of Laboratory Medicine (Volume 6, Issue 2)
DOI	10.11648/j.ajlm.20210602.12
Page(s)	22-26
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Diabetes Mellitus, Arterial Hypertension, COVID-19

References

[1]	Dominguez AN, Valdéz A. COVID-19. Cardiologist's point of view. Cuban Journal of Cardiology and Cardiovascular Surgery. 2020; 26 (1): 951. available at: http://revcardiologia.sld.cu/index.php/revcardiologia/article/download/951/pdf
[2]	Parra-Izquierdo V, Flórez-Sarmiento C, García del Risco F, Romero-Sánchez C. Gastrointestinal symptoms in COVID-19 disease and their implications in Inflammatory Bowel Disease. Colombian Journal of Gastroenterology. 2020; 35: 45-55. Available at: http://www.scielo.org.co/pdf/rcg/v35s1/0120-9957-rcg-35-s1-00045.pdf
[3]	FROM TOMÁS JFÁ. CORONAVIRUS COVID-19; PATHOGENESIS, PREVENTION AND TREATMENT. available at: https://ebevidencia.com/wp-content/uploads/2020/03/CORONAVIRUS-COVID-19-4%C2%AA-Ed-18.03.2020.pdf
[4]	Bermejo PM, Ledo MJV, Rodríguez WB, Jo AHS, Díaz RG, Bravo VN. Fight against epidemic in COVID-19 in Cuba. Organization of epidemiological research. Journal of Scientific Information for the Health Directorate INFODIR. 2020 (32). Available at: http://www.revinfodir.sld.cu/index.php/infodir/article/download/831/1058
[5]	Cubadebate http://www.cubadebate.cu/noticias/
[6]	Alais E. UPDATE ON COVID-19 AND LOOK FROM THE CYSTIC FIBROSIS. Available at: https://www.aamr.org.ar/secciones/coronavirus/covid_y_fq_2020_fin1.pdf
[7]	Prínce A, Claro J, Salabert Tortoló I, Alfonso Salabert I, Morales Díaz M, García Cruz D, et al. High blood pressure: an international health problem. Electronic Medical Journal. 2017; 39 (4): 987-94. Available at: https://www.medigraphic.com/pdfs/revmedele/me-2017/me174m.pdf
[8]	Alarcón IV, Gutiérrez MdCJ. Mexico: chronic degenerative diseases (diabetes mellitus and hypertension) and vulnerability to COVID-19. Available at: https://www.researchgate.net/profile/Iliana_Alarcon/publication/341625708_Mexico_las_enfermedades_cronico_degenerativas_diabetes_mellitus_e_hipertension_arterial_y_la_vulnerabilidad_ante_el_COVID-19/links/5ecc15c94585cabetes-related-Mexico-Diabetes-Certification-MexicoDiabetes-Mel-Diabetes-MexicoDelivery-ecc15c945-856Diabetes -vulnerability-to-COVID-19.pdf
[9]	del Busto JEB, Castellón RL, Pedroso MDM. Cerebrovascular disease and COVID-19. Annals of the Cuban Academy of Sciences. 2020; 10 (2). Available at: http://revistaccuba.sld.cu/index.php/revacc/article/download/802/833
[10]	Guzmán JT. The renin angiotensin aldosterone system, system inhibitor drugs, and COVID-19. Academic Record. 2020; 66 (May): 101-8. Available at: http://revista.uaca.ac.cr/index.php/actas/article/download/344/335
[11]	AADYND GDE, KIDNEY NY. COVID-19 PANDEMIC EMERGENCY. Available at: http://www.aadynd.org.ar/descargas/archivos/rion-aadynd-para-hd-en-emeregencia-covid19--mayo-2020.pdf
[12]	Thais María PU, Raúl AR, Luis AM, editors. HYPERTENSION, DIABETES AND CHRONIC KIDNEY DISEASE AS RISK FACTORS FOR SERIOUS COVID-19. I Virtual Congress of Basic Biomedical Sciences of Granma; at: http://cibamanz2020.sld.cu/index.php/cibamanz/cibamanz2020/paper/view/496/267
[13]	Martínez JAP. Considerations for Cardiologists on the Frontline of COVID-19 Care. Cuban Journal of Cardiology and Cardiovascular Surgery. 2020; 26 (2): 996. Available at: http://revcardiologia.sld.cu/index.php/revcardiologia/article/download/996/pdf
[14]	Salazar MG, Espeche WG, Barochiner J, Leiva C, Ennis IL. Argentine Society of Arterial Hypertension. Available at: http://www.saha.org.ar/files/documents/Comunicado-saha-4-de-mayo.pdf
[15]	Martínez PH, Villaquirán C, Preciado CC, García OM, Gómez MB. Report-COVID-19. Universitas Médica. 2020; 61 (3). Available at: https://revistas.javeriana.edu.co/index.php/vnimedica/article/download/29781/24214/
[16]	Muñoz CAV, Romero M. Level of knowledge about diabetes and metabolic control of type 2 diabetic patients in the Medical Clinic Department of the Pasteur Clinic in Neuquén, Argentina, from February to April 2018. University Research Journal in health. 2019; 1 (1): 23-32.
[17]	Alarcón IV, Gutiérrez MdCJ. Mexico: chronic degenerative diseases (diabetes mellitus and hypertension) and vulnerability to COVID-19.
[18]	Pérez B. Coronavirus and diabetes. Rev chil endocrinol diabetes. 2020: 41.
[19]	Cordo CS, Pagotto V, Cean P, Salzberg S. DIABETES AND COVID-19: CURRENT PHARMACOLOGICAL TREATMENTS.
[20]	Vargas-Uricoechea H. COVID-19 in Colombia and herd immunity: is it time to consider it? Colombian Journal of Endocrinology, Diabetes & Metabolism. 2020; 7 (1): 57-9.
[21]	Pérez-Martínez P, Sánchez FC, Gómez JC, Gómez-Huelgas R. SOLVING ONE OF THE PIECES OF THE PUZLE: COVID-19 AND TYPE 2 DIABETES. Revista Clínica Española. 2020.
[22]	Service Murciano of Health and Service Prevention of Occupational Risks. Procedure for the protection of the health of workers with special vulnerability and sensitivity to COVID-19. 2020.

Cite This Article

Plain Text BibTeX RIS

APA Style

Carlos Miguel Campos Sanchez, Jose Carlos Garcia Roque, Liz Greit Garcia Rodriguez, Laura Adalys Guillen Leon, Juan Miguel Garcia Velazquez, et al. (2021). Arterial Hypertension and Diabetes Mellitus as Risk Factors in the Evolution of Patients with COVID-19. American Journal of Laboratory Medicine, 6(2), 22-26. https://doi.org/10.11648/j.ajlm.20210602.12

Copy | Download

ACS Style

Carlos Miguel Campos Sanchez; Jose Carlos Garcia Roque; Liz Greit Garcia Rodriguez; Laura Adalys Guillen Leon; Juan Miguel Garcia Velazquez, et al. Arterial Hypertension and Diabetes Mellitus as Risk Factors in the Evolution of Patients with COVID-19. Am. J. Lab. Med. 2021, 6(2), 22-26. doi: 10.11648/j.ajlm.20210602.12

Copy | Download

AMA Style

Carlos Miguel Campos Sanchez, Jose Carlos Garcia Roque, Liz Greit Garcia Rodriguez, Laura Adalys Guillen Leon, Juan Miguel Garcia Velazquez, et al. Arterial Hypertension and Diabetes Mellitus as Risk Factors in the Evolution of Patients with COVID-19. Am J Lab Med. 2021;6(2):22-26. doi: 10.11648/j.ajlm.20210602.12

Copy | Download

@article{10.11648/j.ajlm.20210602.12,
  author = {Carlos Miguel Campos Sanchez and Jose Carlos Garcia Roque and Liz Greit Garcia Rodriguez and Laura Adalys Guillen Leon and Juan Miguel Garcia Velazquez and Isbety Acosta Escanaverino and Daniel Rodriguez Hurtado},
  title = {Arterial Hypertension and Diabetes Mellitus as Risk Factors in the Evolution of Patients with COVID-19},
  journal = {American Journal of Laboratory Medicine},
  volume = {6},
  number = {2},
  pages = {22-26},
  doi = {10.11648/j.ajlm.20210602.12},
  url = {https://doi.org/10.11648/j.ajlm.20210602.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajlm.20210602.12},
  abstract = {COVID-19 is one of the most relevant pathologies in recent months, becoming one of the most deadly pandemics that the world has faced; Since the detection of the first cases in Wuhan (China) until today, the evolution of those infected has been a bit unpredictable, although without a doubt comorbidities such as Diabetes Mellitus (DM) and Arterial Hypertension (HTN) have been an essential link in fatality of clinical evolutions and the main cause of transfer to intensive care units. A bibliographic analysis was carried out, using the Scielo, Scopus, EBSCO and Google Academic databases, where information was obtained from twenty-two bibliographic references in order to determine the influence of arterial hypertension and diabetes as risk factors in the evolution of patients with covid 19. Patients diagnosed with COVID-19 who have hypertension and diabetes as a personal medical history are more likely to develop complications during the course of the disease and even die. The control and isolation of these patients is of special importance, taking into account the risk posed by presenting these pathologies. The research work carried out in Cuba maintains the control and knowledge of the health personnel of the state of vulnerable patients.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Arterial Hypertension and Diabetes Mellitus as Risk Factors in the Evolution of Patients with COVID-19
AU  - Carlos Miguel Campos Sanchez
AU  - Jose Carlos Garcia Roque
AU  - Liz Greit Garcia Rodriguez
AU  - Laura Adalys Guillen Leon
AU  - Juan Miguel Garcia Velazquez
AU  - Isbety Acosta Escanaverino
AU  - Daniel Rodriguez Hurtado
Y1  - 2021/04/16
PY  - 2021
N1  - https://doi.org/10.11648/j.ajlm.20210602.12
DO  - 10.11648/j.ajlm.20210602.12
T2  - American Journal of Laboratory Medicine
JF  - American Journal of Laboratory Medicine
JO  - American Journal of Laboratory Medicine
SP  - 22
EP  - 26
PB  - Science Publishing Group
SN  - 2575-386X
UR  - https://doi.org/10.11648/j.ajlm.20210602.12
AB  - COVID-19 is one of the most relevant pathologies in recent months, becoming one of the most deadly pandemics that the world has faced; Since the detection of the first cases in Wuhan (China) until today, the evolution of those infected has been a bit unpredictable, although without a doubt comorbidities such as Diabetes Mellitus (DM) and Arterial Hypertension (HTN) have been an essential link in fatality of clinical evolutions and the main cause of transfer to intensive care units. A bibliographic analysis was carried out, using the Scielo, Scopus, EBSCO and Google Academic databases, where information was obtained from twenty-two bibliographic references in order to determine the influence of arterial hypertension and diabetes as risk factors in the evolution of patients with covid 19. Patients diagnosed with COVID-19 who have hypertension and diabetes as a personal medical history are more likely to develop complications during the course of the disease and even die. The control and isolation of these patients is of special importance, taking into account the risk posed by presenting these pathologies. The research work carried out in Cuba maintains the control and knowledge of the health personnel of the state of vulnerable patients.
VL  - 6
IS  - 2
ER  -

Copy | Download

Author Information

Carlos Miguel Campos Sanchez

Health Faculty, Villa Clara University of Medical Sciences, Villa Clara, Cuba
Jose Carlos Garcia Roque

Health Faculty, Villa Clara University of Medical Sciences, Villa Clara, Cuba
Liz Greit Garcia Rodriguez

Health Faculty, Villa Clara University of Medical Sciences, Villa Clara, Cuba
Laura Adalys Guillen Leon

Health Faculty, Villa Clara University of Medical Sciences, Villa Clara, Cuba
Juan Miguel Garcia Velazquez

Health Faculty, Villa Clara University of Medical Sciences, Villa Clara, Cuba
Isbety Acosta Escanaverino

Health Faculty, Villa Clara University of Medical Sciences, Villa Clara, Cuba
Daniel Rodriguez Hurtado

Health Faculty, Villa Clara University of Medical Sciences, Villa Clara, Cuba

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Carlos Miguel Campos Sanchez, Jose Carlos Garcia Roque, Liz Greit Garcia Rodriguez, Laura Adalys Guillen Leon, Juan Miguel Garcia Velazquez, et al. (2021). Arterial Hypertension and Diabetes Mellitus as Risk Factors in the Evolution of Patients with COVID-19. American Journal of Laboratory Medicine, 6(2), 22-26. https://doi.org/10.11648/j.ajlm.20210602.12

Copy | Download

ACS Style

Carlos Miguel Campos Sanchez; Jose Carlos Garcia Roque; Liz Greit Garcia Rodriguez; Laura Adalys Guillen Leon; Juan Miguel Garcia Velazquez, et al. Arterial Hypertension and Diabetes Mellitus as Risk Factors in the Evolution of Patients with COVID-19. Am. J. Lab. Med. 2021, 6(2), 22-26. doi: 10.11648/j.ajlm.20210602.12

Copy | Download

AMA Style

Carlos Miguel Campos Sanchez, Jose Carlos Garcia Roque, Liz Greit Garcia Rodriguez, Laura Adalys Guillen Leon, Juan Miguel Garcia Velazquez, et al. Arterial Hypertension and Diabetes Mellitus as Risk Factors in the Evolution of Patients with COVID-19. Am J Lab Med. 2021;6(2):22-26. doi: 10.11648/j.ajlm.20210602.12

Copy | Download

@article{10.11648/j.ajlm.20210602.12,
  author = {Carlos Miguel Campos Sanchez and Jose Carlos Garcia Roque and Liz Greit Garcia Rodriguez and Laura Adalys Guillen Leon and Juan Miguel Garcia Velazquez and Isbety Acosta Escanaverino and Daniel Rodriguez Hurtado},
  title = {Arterial Hypertension and Diabetes Mellitus as Risk Factors in the Evolution of Patients with COVID-19},
  journal = {American Journal of Laboratory Medicine},
  volume = {6},
  number = {2},
  pages = {22-26},
  doi = {10.11648/j.ajlm.20210602.12},
  url = {https://doi.org/10.11648/j.ajlm.20210602.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajlm.20210602.12},
  abstract = {COVID-19 is one of the most relevant pathologies in recent months, becoming one of the most deadly pandemics that the world has faced; Since the detection of the first cases in Wuhan (China) until today, the evolution of those infected has been a bit unpredictable, although without a doubt comorbidities such as Diabetes Mellitus (DM) and Arterial Hypertension (HTN) have been an essential link in fatality of clinical evolutions and the main cause of transfer to intensive care units. A bibliographic analysis was carried out, using the Scielo, Scopus, EBSCO and Google Academic databases, where information was obtained from twenty-two bibliographic references in order to determine the influence of arterial hypertension and diabetes as risk factors in the evolution of patients with covid 19. Patients diagnosed with COVID-19 who have hypertension and diabetes as a personal medical history are more likely to develop complications during the course of the disease and even die. The control and isolation of these patients is of special importance, taking into account the risk posed by presenting these pathologies. The research work carried out in Cuba maintains the control and knowledge of the health personnel of the state of vulnerable patients.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Arterial Hypertension and Diabetes Mellitus as Risk Factors in the Evolution of Patients with COVID-19
AU  - Carlos Miguel Campos Sanchez
AU  - Jose Carlos Garcia Roque
AU  - Liz Greit Garcia Rodriguez
AU  - Laura Adalys Guillen Leon
AU  - Juan Miguel Garcia Velazquez
AU  - Isbety Acosta Escanaverino
AU  - Daniel Rodriguez Hurtado
Y1  - 2021/04/16
PY  - 2021
N1  - https://doi.org/10.11648/j.ajlm.20210602.12
DO  - 10.11648/j.ajlm.20210602.12
T2  - American Journal of Laboratory Medicine
JF  - American Journal of Laboratory Medicine
JO  - American Journal of Laboratory Medicine
SP  - 22
EP  - 26
PB  - Science Publishing Group
SN  - 2575-386X
UR  - https://doi.org/10.11648/j.ajlm.20210602.12
AB  - COVID-19 is one of the most relevant pathologies in recent months, becoming one of the most deadly pandemics that the world has faced; Since the detection of the first cases in Wuhan (China) until today, the evolution of those infected has been a bit unpredictable, although without a doubt comorbidities such as Diabetes Mellitus (DM) and Arterial Hypertension (HTN) have been an essential link in fatality of clinical evolutions and the main cause of transfer to intensive care units. A bibliographic analysis was carried out, using the Scielo, Scopus, EBSCO and Google Academic databases, where information was obtained from twenty-two bibliographic references in order to determine the influence of arterial hypertension and diabetes as risk factors in the evolution of patients with covid 19. Patients diagnosed with COVID-19 who have hypertension and diabetes as a personal medical history are more likely to develop complications during the course of the disease and even die. The control and isolation of these patients is of special importance, taking into account the risk posed by presenting these pathologies. The research work carried out in Cuba maintains the control and knowledge of the health personnel of the state of vulnerable patients.
VL  - 6
IS  - 2
ER  -

Copy | Download